hi all
here is a partial listing of the articles referring to parkinson
added to PubMed in the past 30 days; which puts my current research
'barometer' reading at 137
if you want to look at the abstract of one of these
enter the PMID number into the search window at the PubMed site at:
http://www.ncbi.nlm.nih.gov/PubMed/
if you want to look at the full article,
the medical journal may be available on line through PubMed;
otherwise, try your favourite medical library
(or your favourite neurologist's waiting room!)
i used to try to post all of the pubmed abstracts dealing with parkinsons
so as to get them all into our list archives,
(instead of just the titles, which this posting achieves)
but
the volume got too heavy!
but
i'm not complaining!
janet
--------------------------------------------------------------------
Human and Mouse alpha-Synuclein Genes: Comparative Genomic Sequence
Analysis and Identification of a Novel Gene Regulatory Element.
PMID: 11156617
A neural model of working memory processes in normal subjects, Parkinson's
disease and schizophrenia for fMRI design and predictions.
PMID: 11156204; UI: 21027899
Timed tests in the clinical assessment of motor function in Parkinson's
disease.
PMID: 11155348; UI: 21028444
Postural instability in Parkinson's disease: a comparison with and without
a concurrent task.
PMID: 11154931
Nicotinamide-N-methyltransferase is higher in the lumbar cerebrospinal
fluid of patients with Parkinson's disease.
PMID: 11154840
Nonlinear analysis of brain activity in magnetic influenced Parkinson
patients.
PMID: 11154103; UI: 21026994
Visual hallucinations induced by deep brain stimulation in Parkinson's
disease.
PMID: 11154099; UI: 21026988
Adverse drug reactions to selegiline: a review of the French
pharmacovigilance database.
PMID: 11154095; UI: 21026984
A comparison of dopamine agonists and catechol-O-methyltransferase
inhibitors in Parkinson's disease.
PMID: 11154093; UI: 21026982
Parkinson's disease therapy: tailoring choices for early and late disease,
young and old patients.
PMID: 11154092; UI: 21026981
Nonparkinsonian tremors.
PMID: 11154090; UI: 21026979
Causes of death in a community-based study of Parkinson's disease.
PMID: 11153892; UI: 21026748
The psychological refractory period in Parkinson's disease.
PMID: 11153866; UI: 21026727
CB1 Cannabinoid Receptor Inhibits Synaptic Release of Glutamate in Rat
Dorsolateral Striatum.
PMID: 11152748
Dopamine D-1/D-5 Receptor Activation Is Required for Long-Term Potentiation
in the Rat Neostriatum In Vitro.
PMID: 11152712
Evidence for a Partially-Folded Intermediate in {alpha}-Synuclein Fibril
Formation.
PMID: 11152691
Levodopa, bromocriptine and selegiline modify cardiovascular responses in
Parkinson's disease.
PMID: 11151420; UI: 21025896
Is clonidine growth hormone stimulation a good test to differentiate
multiple system atrophy from idiopathic Parkinson's disease?
PMID: 11151417; UI: 21025893
One Further Case of Pancytopenia Induced by Olanzapine in a Parkinson's
Disease Patient.
PMID: 11150845
Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine
lesion in the substantia nigra(1).
PMID: 11150495
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for
mitochondrial complex I activity.
PMID: 11149904
Too many treatments for Parkinson's disease: another look.
PMID: 11149259; UI: 21025100
Too many treatments for Parkinson's disease: another look.
PMID: 11149258; UI: 21025099
Single or continuous injection of glial cell line-derived neurotrophic
factor in the striatum induces recovery of the nigrostriatal dopaminergic
system.
PMID: 11149247; UI: 21025095
Pesticides and parkinsonism: is there an etiological link?
PMID: 11148671; UI: 21025168
OLFACTION.
PMID: 11148312
Competency to consent to medical treatment in cognitively impaired patients
with Parkinson's disease.
PMID: 11148230
Relationship of substantia nigra echogenicity and motor function in elderly
subjects.
PMID: 11148229
Welding-related parkinsonism: Clinical features, treatment, and
pathophysiology.
PMID: 11148228
Environmental toxins accelerate Parkinson's disease onset.
PMID: 11148226
Pallidotomy for parkinson disease: a review of contemporary literature.
PMID: 11147896; UI: 21023396
Pulsatile stimulation of dopamine receptors and levodopa-induced motor
complications in Parkinson's disease: implications for the early use of
COMT inhibitors.
PMID: 11147513; UI: 21023050
The place of COMT inhibitors in the armamentarium of drugs for the
treatment of Parkinson's disease.
PMID: 11147512; UI: 21023049
Practical issues with COMT inhibitors in Parkinson's disease.
PMID: 11147511; UI: 21023048
Issues important for rational COMT inhibition.
PMID: 11147507; UI: 21023044
Levodopa in the treatment of Parkinson's disease.
PMID: 11147506; UI: 21023042
The evolution and origin of motor complications in Parkinson's disease.
PMID: 11147505; UI: 21023043
Imaging of dopamine transporters with technetium-99m TRODAT-1 and single
photon emission computed tomography.
PMID: 11147397; UI: 21000520
Ascorbic acid increases the yield of dopaminergic neurons derived from
basic fibroblast growth factor expanded mesencephalic precursors.
PMID: 11146004
Mitochondria deficient in complex I activity are depolarized by hydrogen
peroxide in nerve terminals: relevance to Parkinson's disease.
PMID: 11146003
N-Acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative
stress and cell cytotoxicity: effects on ss-amyloid secretion and tau
phosphorylation.
PMID: 11145996
The solubility of alpha-synuclein in multiple system atrophy differs from
that of dementia with Lewy bodies and Parkinson's disease.
PMID: 11145981
Parkinson's disease and impaired chemosensitivity to hypoxia.
PMID: 11145519; UI: 21017735
Parkinson's disease and impaired chemosensitivity to hypoxia.
PMID: 11145518; UI: 21017734
An open-label, multicentre clinical trial to determine the levodopa
dose-sparing capacity of pramipexole in patients with idiopathic
Parkinson's disease.
PMID: 11145006; UI: 21017668
Amantadine infusion in treatment of motor fluctuations and dyskinesias in
Parkinson's disease.
PMID: 11145005; UI: 21017667
FDG- and Dopa-PET in postencephalitic parkinsonism.
PMID: 11145004; UI: 21017666
Grafting of encapsulated dopamine-secreting cells in Parkinson's disease:
long-term primate study.
PMID: 11144970; UI: 21017689
Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine
pharmacological manipulation and adrenal co-graft transplantation.
PMID: 11144958; UI: 21017677
Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell
line-derived neurotrophic factor.
PMID: 11144955; UI: 21017674
The localization and functional contribution of striatal aromatic L-amino
acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in
rodent parkinsonian models.
PMID: 11144954; UI: 21017673
Gamma knife thalamotomy for treatment of tremor: long-term results.
PMID: 11143229; UI: 21004889
Evaluation of gamma thalamotomy for parkinsonian and other tremors:
survival of neurons adjacent to the thalamic lesion after gamma thalamotomy.
PMID: 11143228; UI: 21004888
Judgment of disability stages in Parkinson disease patients due to
pathological tremor of index finger.
PMID: 11142111; UI: 21022900
Restoration of function by neural transplantation in the ischemic brain.
PMID: 11142041; UI: 21022830
Neuropathology of fetal nigra transplants for Parkinson's disease.
PMID: 11142034; UI: 21022824
Clinical observations after neural transplantation in Parkinson's disease.
PMID: 11142032; UI: 21022822
The primate model of Parkinson's disease: its usefulness, limitations, and
importance in directing future studies.
PMID: 11142031; UI: 21022821
Transplantation in the rat model of Parkinson's disease: ectopic versus
homotopic graft placement.
PMID: 11142030; UI: 21022820
Improving the survival of grafted embryonic dopamine neurons in rodent
models of Parkinson's disease.
PMID: 11142029; UI: 21022819
Neuro-ophthalmology of movement disorders.
PMID: 11141633; UI: 21022382
Hepatic disposition of neurotoxins and pesticides.
PMID: 11140828; UI: 21021100
Therapeutic advances in idiopathic Parkinsonism.
PMID: 11139811
Gene therapy for Parkinson's disease: review and update.
PMID: 11139810
Drosophila models of human neurodegenerative disease.
PMID: 11139281
Dopamine mercapturate can augment dopaminergic neurodegeneration.
PMID: 11139134; UI: 21020082
Resistance training and gait function in patients with Parkinson's disease.
PMID: 11138953; UI: 21019901
CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's
disease.
PMID: 11138845; UI: 21019791
The parkinsonian models: invertebrates to mammals.
PMID: 11138723; UI: 21019669
Parkinson's disease: nuclear medicine in the spotlight.
PMID: 11138674; UI: 21019621
Proteasomal function is impaired in substantia nigra in Parkinson's disease.
PMID: 11137760
Deficits in sensorimotor control during precise hand movements in
Huntington's disease.
PMID: 11137666
Investigation of non-linear properties of multichannel EEG in the early stages
of Parkinson's disease.
PMID: 11137659
Lymphocyte populations in Parkinson's disease and in rat models of
parkinsonism.
PMID: 11137586
Risk factors for hip fracture among elderly patients with Parkinson's disease.
PMID: 11137512
Possible extrapyramidal system degradation in Parkinson's disease.
PMID: 11136999; UI: 20578677
Heart rate variability in patients with untreated Parkinson's disease.
PMID: 11136353; UI: 20577515
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease
and multiple system atrophy measured by proton magnetic resonance
spectroscopy.
PMID: 11136352; UI: 20577514
A two-fold difference in the age-adjusted prevalences of Parkinson's
disease between the island of als and the faroe islands.
PMID: 11136351; UI: 20577513
Role of dopamine D1 and D2 receptors in the micturition reflex in conscious
rats.
PMID: 11135387
Parkinson's disease as multifactorial oxidative neurodegeneration:
implications for integrative management.
PMID: 11134975; UI: 20577592
Parkinson's: better living through chemicals?
PMID: 11134974; UI: 20577591
Time-course and dose-response study on the effects of chronic L-DOPA
administration on striatal dopamine levels and dopamine transporter
following MPTP toxicity.
PMID: 11134595
--------------------------------------------------------------------
janet paterson, an akinetic rigid subtype parkie
53 now / 44 dx cd / 43 onset cd / 41 dx pd / 37 onset pd
TEL: 613 256 8340 SMAIL: PO Box 171 Almonte Ontario K0A 1A0 Canada
EMAIL: [log in to unmask] URL: http://www.geocities.com/janet313/
